20 May 2013
Keywords: Emergent BioSolutions, BioThrax, Government contract, Anthrax
Article | 04 October 2011
Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government with 44.75 million doses ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 October 2011
17 May 2013
© 2013 thepharmaletter.com